FDG-PET predicts survival and distant metastasis in oral squamous cell carcinoma

Oral Oncology

Volumn 45, Issue 7, 2009, Pages 569-573

  Suzuki, Hidenori ^a,b   Hasegawa, Yasuhisa ^a   Terada, Akihiro ^a   Hyodo, Ikuo ^a   Nakashima, Tsutomu ^b   Nishio, Masami ^c   Tamaki, Tsuneo ^c  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Nagoya PET Imaging Center   (Japan)

Author keywords

Distant metastasis; FDG PET; Oral squamous cell carcinoma; Survival

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; DISTANT METASTASIS; DRUG UPTAKE; FEMALE; HUMAN; MALE; MOUTH CARCINOMA; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; JAPAN; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MOUTH NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS;

EID: 67449108664     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2008.07.009     Document Type: Article

References (27)

1. Kim S.Y., Roh J.L., Kim J.S., Ryn C.H., Lee J.H., Cho K.J., et al. Utility of FDG PET in patients with squamous cell carcinomas of the oral cavity. Eur J Surg Oncol 34 2 (2008) 208-215
2. 18F] FDG-PET for surveillance of oral squamous cell carcinoma after surgical salvage therapy. Oral Oncol 42 3 (2006) 297-305
3. Kitagawa Y., Sano K., Nishizawa S., Nakamura M., Ogasawara T., Sadato N., et al. FDG-PET for prediction of tumor aggressiveness and response to intra-arterial chemotherapy and radiotherapy in head and neck cancer. Eur J Nucl Med Mol Imaging 30 1 (2003) 63-712
4. Maemura K., Takao S., Shinchi H., Noma H., Mataki Y., Kurahara H., et al. Role of positron emission tomography in decisions on treatment strategies for pancreatic cancer. J Hepatobiliary Pancreat Surg 13 4 (2006) 435-441
5. Vansteenkiste J., Fischer B.M., Dooms C., and Mortensen J. Positron-emission tomography in prognostic and therapeutic assessment of lung cancer: systemtatic review. Lancet Oncol 5 9 (2004) 531-540
6. Sachs S., Bilfinger T.V., Komaroff E., and Franceschi D. Increased standardized uptake value in the primary lesion predicts nodal or distant metastases at presentation in lung cancer. Clin Lung Cancer 6 5 (2005) 310-313
7. Ryan W.R., Fee Jr. W., Le Q.T., and Pinto H.A. Positron-emission tomography for surveillance of head and neck cancer. Laryngoscope 115 4 (2005) 645-650
8. Kunkel M., Reichert T.E., Benz P., Lehr H.A., Jeong J.H., Wieand S., et al. Overexpression of Glut-1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma. Cancer 97 4 (2003) 1015-1024
9. Halfpenny W., Hain S.F., Biassoni L., Maisey M.N., Sherman J.A., and McGurk M. FDG-PET. A possible prognostic factor in head and neck cancer. Br J Cancer 86 4 (2002) 512-516
10. Schwartz D.L., Rajendran J., Yueh B., Coltrera M.D., Leblanc M., Eary J., et al. FDG-PET prediction of head and neck squamous cell cancer outcomes. Arch Otolaryngol Head Neck Surg 130 12 (2004) 1361-1367
11. Allal A.S., Dulguerov P., Allaoua M., Haenggeli C.A., El-Ghanziel A., Lehmann W., et al. Standardized uptake value of 2-[(18)F] fluoro-2-deoxy-d-glucose in predicting outcome in head and neck carcinomas treated by radiotherapy with or without chemotherapy. J Clin Oncol 20 5 (2002) 1398-1404
12. Kim S.Y., Roh J.L., Kim M.R., Kim J.S., Choi S.H., Nam S.Y., et al. Use of 18F-FDG PET for primary treatment strategy in patients with squamous cell carcinoma of the oropharynx. J Nucl Med 48 5 (2007) 752-757
13. 18F]fluoro-2-deoxy-d-glucose. Int J Radiat Oncol Biol Phys 59 5 (2004) 1295-1300
14. Schuetze S.M., Rubin B.P., Vernon C., Hawkins D.S., Bruckner J.D., Conrad III E.U., et al. Use of positron emission tomography in localized extremity soft tissue sarcoma treated with neoadjuvant chemotherapy. Cancer 103 2 (2005) 339-348
15. Vansteenkiste J.F., Stroobants S.G., Dupont P.J., De Leyn P.R., Verbeken E.K., Deneffeb J., et al. Prognostic importance of the standardized uptake value on (18)F-fluoro-2-deoxy-glucose-positron emission tomography scan in non- small-cell lung cancer: an analysis of 125 cases. Leuven Lung Cancer Group. J Clin Oncol 17 10 (1999) 3201-3206
16. van Baardwijk A., Dooms C., van Suylen R.J., Verbeken E., Hochstenbag M., Dehing-Oberije C., et al. The maximum uptake of (18)F-deoxyglucose on positron emission tomography scan correlates with survival, hypoxia inducible factor-1alpha and GLUT-1 in non-small cell lung cancer. Eur J Cancer 43 9 (2007) 1392-1398
17. Zhang Z.J., Chen J.H., Meng L., Du J.J., Zang L., Liu Y., et al. 18F-FDG uptake as a biologic factor predicting outcome in patients with resected non-small-cell lung cancer. Chin Med J 120 2 (2007) 125-131
18. de Geus-oei L.F., van der Heijden H.F., Corstens F.H., and Oyen W.J. Predictive and prognostic value of FDG-PET in nonsmall-cell lung cancer: a systematic review. Cancer 110 8 (2007) 1654-1664
19. Kidd E.A., Siegel B.A., Dehdashti F., and Grigsby P.W. The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival. Cancer 110 8 (2007) 1738-1744
20. Liao C.T., Wang H.M., Chang J.T., Ng S.H., Hsueh C., Lee L.Y., et al. Analysis of risk factors for distant metastases in squamous cell carcinoma of the oral cavity. Cancer 110 7 (2007) 1501-1508
21. Rahima B., Shingaki S., Nagata M., and Saito C. Prognostic significance of perineural invasion in oral and oropharyngeal carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 97 4 (2004) 423-431
22. Shintani S., Matsuura H., Hasegawa Y., Nakayama B., and Hasegawa H. Regional lymph node involvement affects the incidence of distant metastasis in tongue squamous cell carcinomas. Anticancer Res 15 4 (1995) 1573-1576
23. Kowalski L.P., Carvalho A.L., Martins Priante A.V., and Magrin J. Predictive factors for distant metastasis from oral and oropharyngeal squamous cell carcinoma. Oral Oncol 41 5 (2005) 534-541
24. Goto M., Tsukamoto T., Inada K., Mizoshita T., Ogawa T., Terada A., et al. Loss of p21WAF/CIP1 expression in invasive fronts of oral tongue squamous cell carcinomas is correlated with tumor progression and poor prognosis. Oncol Rep 14 4 (2005) 837-846
25. Wong L.Y., Wei W.I., Lam L.K., and Yuen A.P. Salvage of recurrent head and neck squamous cell carcinoma after primary curative surgery. Head Neck 25 11 (2003) 953-959
26. Goto M., Hasegawa Y., Terada A., Hyodo I., Hanai N., Ijichi K., et al. Prognostic significance of late cervical metastasis and distant failure in patients with stage I and II oral tongue cancers. Oral Oncol 41 1 (2005) 62-69
27. Katayama A., Bandoh N., Kishibe K., Takahara M., Ogino T., Nonaka S., et al. Expression of matrix metalloproteinases in early-stage oral squamous cell carcinoma as predictive indicators for tumor metastases and prognosis. Clin Cancer Res 10 2 (2004) 634-640